IL17A and neoplasm: As a result, many authors [16,17,18,19] have hypothesised that IL-17 might promote tumour angiogenesis by stimulating the vascular endothelial growth factor (VEGF) [20], which, in turn, may increase microvascular permeability and the release of endothelial-derived nitric oxide (NO) [21,22,23].